Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 2 Sarcoma 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 45 Specimen Handling 45 Biopsy 37 Magnetic Resonance Spectroscopy 36 Paclitaxel 22 Nivolumab 21 Carboplatin 21 Gemcitabine 20 Radiosurgery 18 Irinotecan 16 Ipilimumab 13 Cisplatin 13 Capecitabine 12 130-nm albumin-bound paclitaxel 12 trastuzumab deruxtecan 11 Taxes 11 Pemetrexed 11 Cetuximab 11 olaparib 10 Leucovorin 10 Fluorouracil 10 Cyclophosphamide 10 durvalumab 9 Oxaliplatin 9 Bevacizumab 9 abemaciclib 8 X-Rays 8 Fulvestrant 8 Drug Therapy 8 palbociclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × glasdegib × 90 days × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡